Please assess the completion status of the following clinical trial:

Trial Title: Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Naturally postmenopausal women of any age with at least one ovary~* Diagnosis of Hypoactive Sexual Desire Disorder, generalized acquired type,of at least six months duration~* Stable, monogamous heterosexual relationship for at least one year~* Willing to discuss sexual issues~* Willing to engage in sexual activity at least once a month~* Normal Pap smear~* Normal mammogram~* Normal uterine lining~* Able to comply with daily use of handheld data entry device~Exclusion criteria:~* Sexual dysfunctions other than HSDD, such as Sexual Aversion Disorder, Substance-induced Sexual Dysfunction, Dyspareunia, Vaginismus, Gender Identity Disorder, Paraphilia and Sexual Dysfunction due to a General Medical Condition~* Partner with inadequately treated organic or psychosexual dysfunction~* Sexual function impaired by psychiatric disorder~* Sexual function impaired by gynecological disorder~* Major Depression~* Suicidal behavior or ideation~* Major life stress that could impair sexual function~* Substance abuse

- Gender: FEMALE
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- flibanserin 100mg (Type: EXPERIMENTAL): flibanserin 100mg po qd
- placebo (Type: PLACEBO_COMPARATOR): placebo one tablet po qd

Based on this trial design, predict the completion outcome and termination type (if applicable).